Sol-Gel Technologies Property, Plant, and Equipment 2016-2024 | SLGL
Sol-Gel Technologies property, plant, and equipment from 2016 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Sol-Gel Technologies Annual Property, Plant, and Equipment (Millions of US $) |
2023 |
$0 |
2022 |
$1 |
2021 |
$1 |
2020 |
$2 |
2019 |
$2 |
2018 |
$3 |
2017 |
$2 |
2016 |
$1 |
2015 |
$1 |
Sol-Gel Technologies Quarterly Property, Plant, and Equipment (Millions of US $) |
2024-06-30 |
$0 |
2024-03-31 |
$0 |
2023-12-31 |
$0 |
2023-09-30 |
$0 |
2023-06-30 |
$1 |
2023-03-31 |
$1 |
2022-12-31 |
$1 |
2022-09-30 |
$1 |
2022-06-30 |
$1 |
2022-03-31 |
$1 |
2021-12-31 |
$1 |
2021-09-30 |
$1 |
2021-06-30 |
$1 |
2021-03-31 |
$2 |
2020-12-31 |
$2 |
2020-09-30 |
$2 |
2020-06-30 |
$2 |
2020-03-31 |
$2 |
2019-12-31 |
$2 |
2019-09-30 |
$2 |
2019-06-30 |
$2 |
2019-03-31 |
$3 |
2018-06-30 |
$2 |
2018-03-31 |
|
2017-12-31 |
|
2017-09-30 |
|
2017-06-30 |
|
2016-12-31 |
|
2015-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.013B |
$0.002B |
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
|